Raffles Medical CEO tightens grip with $0.99 share sweep

Dr Loo Choon Yong bought 159,100 shares, raising his total interest to 56.29%.

Dr Loo Choon Yong, CEO of Raffles Medical Group Ltd, has acquired an additional 159,100 ordinary shares at $0.99 per share, according to a SGX filing dated 26 March.

The acquisition increases Loo’s direct shareholding to 251.92 million shares, representing 13.69% of the company’s total ordinary voting shares.

Combined with deemed interests held through Raffles Medical Holdings Pte Ltd, his total interest now stands at 56.29% of the company.

The filing notes that Loo’s deemed interest arises from shares held via Raffles Medical Holdings Pte Ltd, where he serves as director and shareholder with the transaction executed through the market.

Follow the link for more news on

Raffles Medical Group

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia